UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000042089
Receipt No. R000047945
Scientific Title Examination of differences in EEG frequency changes between inhalation anesthesia and total intravenous anesthesia
Date of disclosure of the study information 2020/10/12
Last modified on 2022/04/03 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of differences in EEG frequency changes between inhalation anesthesia and total intravenous anesthesia
Acronym Examination of differences in EEG frequency changes between inhalation anesthesia and total intravenous anesthesia
Scientific Title Examination of differences in EEG frequency changes between inhalation anesthesia and total intravenous anesthesia
Scientific Title:Acronym Examination of differences in EEG frequency changes between inhalation anesthesia and total intravenous anesthesia
Region
Japan

Condition
Condition Patients undergoing surgery with general anesthesia
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The effects of anesthetics on electroencephalogram(EEG) is very. The effect is depending on type of anesthetics. For example, sevoflurane, an inhaled anesthetics, increases proportion of EEG alpha wave compared to propofol, an intravenous anesthetics. This study aims to investigate effect of desflurane, another inhaled anesthetics, and propofol on frequency distribution of EEG.
Basic objectives2 Others
Basic objectives -Others Some patient develop delirium after surgery with general anesthesia. Among various causative factor, anesthetics itself could be responsible for development of the delirium. We hypothesized analysis of character of EEG frequency proportion by various anesthetics could predict potency of delirium development.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Differences in EEG frequency distribution between desflurane and propofol from the introduction of general anesthesia to the start of surgery
Key secondary outcomes Perioperative psychiatric and general physio-pathological condition including liver, kidney etc

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Desflurane
Interventions/Control_2 Propofol
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patients undergoing surgery with general anesthesia
Key exclusion criteria Patients with skin lesions on the forehead, where the BIS monitor is attached, neurosurgery, patients with cerebrovascular complications, patients with psychiatric disorders, patients with opioid addiction
Target sample size 140

Research contact person
Name of lead principal investigator
1st name Tetsuya
Middle name
Last name Kushikata
Organization Hirosaki University Graduate School of Medicine
Division name Anesthesiology
Zip code 036-8562
Address Aomori Prefecture, Hirosaki City, 5 Zaifucho
TEL 0172-33-5111
Email tetsuyak@hirosaki-u.ac.jp

Public contact
Name of contact person
1st name Tetsuya
Middle name
Last name Kushikata
Organization Hirosaki University Graduate School of Medicine
Division name Anesthesiology
Zip code 036-8562
Address Aomori Prefecture, Hirosaki City, 5 Zaifucho
TEL 0172-33-5111
Homepage URL
Email tetsuyak@hirosaki-u.ac.jp

Sponsor
Institute Hirosaki University Graduate School of Medicine
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hirosaki University Graduate School of Medicine
Address Aomori Prefecture, Hirosaki City, 5 Zaifucho
Tel 0172-33-5111
Email tetsuyak@hirosaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 10 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 07 Month 31 Day
Date of IRB
2020 Year 07 Month 31 Day
Anticipated trial start date
2020 Year 10 Month 12 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 10 Month 12 Day
Last modified on
2022 Year 04 Month 03 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047945